Recommended timing and frequency of screening for colorectal cancer is based on assessment of patient risk.
- AVERAGE CRC RISK CRITERIA: Age 50 and over (45 for African Americans)
- No personal history of adenoma, CRC, or inflammatory bowel disease (IBD, ulcerative colitis or Crohn’s colitis)
- No family history (no 1st-degree relatives or two or more 2nd-degree relatives with CRC or related cancers [see below])
Recommended Screening for AVERAGE RISK:
- Colonoscopy. If normal, repeat every 10 years
If colonoscopy unavailable, annual fecal occult blood test and/or flexible sigmoidoscopy every five years, or double-contrast barium enema every five years.
INCREASED CRC RISK CRITERIA:
- Personal history of CRC or adenoma
- Personal history of endometrial or ovarian cancer prior to age 60
- IBD at any age
- Family history of 1st-degree relatives with CRC or adenomas or two or more 2nd-degree relatives with CRC; or a clustering of CRC or related cancers in family (see below)
Recommended screening for patients with a personal history of adenomas
- For patients with two or fewer tubular adenomas smaller than 1 cm, repeat colonoscopy within five years. If then normal, repeat every 5-10 years.
- For patients with advanced or multiple adenomas (high-grade dysplasia/carcinoma in situ or larger than 1 cm or greater than 25% villous or 3-10 polyps) repeat colonoscopy within three years. If normal, repeat within five years.
- More than 10 adenomas or greater than 15 cumulative adenomas in a 10-year period, consider a polyposis syndrome; repeat in one year if all polyps removed.
Recommended screening for patients with personal history of CRC resected with curative intent
- Colonoscopy within 3-6 months if no or incomplete preoperative colonoscopy, then again in one year
- If adenomas are found, repeat in 1-3 years; if normal, repeat in 2-3 years, then every 5 years.
Recommended screening for patients with personal history of endometrial cancer before 60
- Begin colonoscopy at 40 (or at age of diagnosis of ovarian/endometrial cancer)
- Repeat at 5-year intervals if normal
Recommended screening for patients with IBD
- Initiate screening 8-10 years after onset of symptoms.
- Colonoscopy every 1-2 years with biopsies every 10 cm.
Recommended for patients with positive family history of CRC
- 1st-degree relative or two or more 2nd-degree relatives with CRC: colonoscopy beginning at age 40 or 10 years prior to onset of earliest cancer in family
- 1st-degree relative with adenomas: colonoscopy beginning at the earlier of 50 or the age of diagnosis in the relative
- A 2nd-degree or 3rd-degree relative with colorectal cancer: screen as average risk but individualized evaluation including careful family history is encouraged
HEREDITARY RISK OF CRC
Features suggesting hereditary risk of CRC in an individual or family:
- CRC prior to age 50
- Clustering of same or related cancers in close relatives: CRC, endometrial, ovarian, duodenal/small bowel, biliary, brain, ureteral/renal pelvis, sebaceous adenomas or sebaceous carcinomas
- Multiple CRCs or greater than 10 adenomas in same individual
- Certain pathologic features of the CRC
- Three family members in two generations (one relative younger than 50) with any of the above related cancers
If patients meet criteria for familial adenomatous polyposis, its attenuated form, or hereditary nonpolyposis colorectal cancer, risk assessment and genetic counseling by trained counselors should be considered. Genetic counseling is advised whenever genetic testing is offered.
Surveillance: inherited predisposition for FAP
- Colonoscopy beginning at age 10-12, then sigmoidoscopy yearly. This screening should continue unless proven negative through gene testing (then screen every 7-10 years in case of false negative).
- If no adenomas have developed by age 25, likelihood of FAP is reduced and screening interval may be expanded (every 2 years till 34, every 3 years till 44, every 3-5 years thereafter)
Surveillance: inherited predisposition for HNPCC
- Colonoscopy at age 20-25 or 10 years younger than youngest age of diagnosis in family. Repeat every 1-2 years.
- Consider evaluations for associated malignancies based on family history.
Additional considerations for women at risk for HNPCC
- Patient education and prompt response to endometrial cancer symptoms
- Annual screening for endometrial cancer with transvaginal ultrasound and office endometrial sampling as well as screening for ovarian cancer (day 1-10 of cycle for premenopausal women) and CA-125 every 6-12 months. Screening should begin at age 30-35 or 5-10 years younger than earliest age of diagnosis of cancers in family.
- Prophylactic hysterectomy and bilateral salpingo-oophorectory is risk-reducing option after child-bearing is completed.
The Vanderbilt Hereditary Colorectal Cancer Registry offers resources for physicians and for patients and families, including cancer screening and surveillance recommendations, and genetic counseling and testing for high-risk individuals. To learn more, contact Duveen Sturgeon, R.N., (615) 322-1590 or (800) 340-7752 or www.vicc.org/hccr.
References:
NCCN Clinical Practice Guidelines in Oncology: Colorectal Cancer Screening, Version 1.2007, National Comprehensive Cancer Network. Available online at www.nccn.org, last accessed Feb. 14, 2008
Presented in Partnership by Nashville Medical News and Vanderbilt University Medical Center
All source data for this article has been provided by
March 2008
Click here for a PDF of this article